Neurimmune introduced BIIB037, a monoclonal antibody that Neurimmune’s partner Biogen Idec of Cambridge, Massachusetts, will push into human trials this year. At the 10th International AD/PD Conference in Barcelona, Spain, Neurimmune introduced BIIB037, a monoclonal antibody partnered with Biogen Idec of Cambridge, Massachusetts, for the teratment of Alzheimer’s disease.
Neurimmune introduced BIIB037
10.03.2011
